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Flutamide (a,a,a-trifluoro-2-methyl-4'-nitro-m-propionotoluidide), at daily oral doses of 20 
mg/day for 24 days, reduced the number and size of skin sebaceous gland cells, and reduced 
sebum production in ovariectomized, testosterone-stimulated rats. The weight of the 
preputial glands was also reduced. 
Unilateral topical application of flutamide (0 .1-3.0 mg/day) to flank organs (androgen-sen-
sitive cutaneous sebaceous structures) of testosterone propionate-treated female hamsters for 
14 days resulted in bilateral reductions in flank organ weight and in inhibition of in vitro 
incorporation of 14 C from sodium [l- 14C]acetate into lipids. Flutamide inhibition of flank 
organ weight paralleled the drug effect on lipogenesis. 
Unilateral topical application of flutamide to flank organs of intact male hamsters for 14 
days resulted in significant bilateral reductions of flank organ weight at doses as low as 0.375 
mg/day (the lowest dose tested). These weight changes were marked by reduction in 
sebaceous gland size, accompanied by focal cytoplasmic degeneration, and reductions in 
cytoplasmic organelles and in the size of the lipid bodies. Flutamide did not, however, 
seemingly alter the pattern of endogenous total lipids in sebaceous glands, nor did it alter 
the pattern of 14 C-incorporation into the lipids of male flank organ epidermis and isolated 
sebaceous glands, when compared to control, untreated preparations. 
Sebaceous glands are holocrine glands whose 
secretion, sebum, is released by the total break-
down of the secreting cells. That androgens cause 
hypertrophy and hyperplasia of these glands, and 
stimulate their physiologic activity, is well known ; 
for example, the effects have been shown in rats 
[1 -3], rabbits [4], hamsters [5] , and in man [6]. 
These findings are of clinical interest since andro-
gen-enhanced sebum production has been impli-
cated in the etiology of acne [7-10]. 
Several progestins having antiandrogenic prop-
erties, including cyproterone acetate and 17 a-
methyl-B-nortestosterone, inhibit androgen-
stimulated sebum production in rats [11- 14) and 
in man [15-20]. Results of clinical acne treatment 
with these and other presently available antiandro-
gens have thus far been equivocal [16, 17,20,21 ], 
possibly due to their progestational activity; how-
ever , the usefulness of more potent agents, without 
progestational and/or other hormonal effects, re-
mains intriguing. 
The potent antiandrogenic activity and general 
biologic profile of flutamide (a,a,a-trifluoro-2-
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methyl-4' -nitro-m-propionotoluidide) * have been 
described previously [22,23]. As an antiandrogen 
this compound is at least as active as cyproterone 
acetate, but importantly, is free of hormonal activ-
ity [23]. We now wish to describe some effects of 
flutamide on sebaceous gland activity in rats and 
hamsters. In the present study we investigated this 
drug's effectiveness in reducing sebum secretion in 
androgen-stimulated rats and in affecting such 
androgen-sensitive target tissues as the rat prepu-
tial gland. Inhibition of these endpoints has been 
considered suggestive of high antisebum activity in 
man [24,25]. Use of the hamster flank organ has 
already been proposed as an adjunct to methodol-
ogy for assaying the ability of test compounds to 
affect s.ebaceous gland growth [26,27 ]. Further, we 
have determined flutamide 's effects on sebaceous, 
cell count in rat skin , and on 14C-lipogenesis in 
whole hamster flank organ and isolated sebaceous 
glands. 
MATERIALS AND METHODS 
Studies in Ovariectomized Rats 
The effects of flutamide were determined by measuring 
skin sebaceous cell count and preputial gland weight of 
mature rats (350-400 gm), ovariectomized 3 months prior 
to treatment. Groups of 5 Charles River (Wilmington, 
Mass.) CD strain animals were treated with testosterone 
*Synthesized by Dr. E . Gold, Medicinal Chemistry 
Department, Schering Corporation, Bloomfield, New 
Jersey. 
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(0.4 mg/day, s.c.) alone or in combination with flutamide 
(20 mg/day, p.o., in aqueous carboxymethylcellulose) 
daily for 24 days. This dose was chosen on the basis of one 
author's (R. N.) experience with the antiandrogenic 
properties of this compound. Animals were sacrificed on 
the 25th day after initiation of treatment and the 
preputial glands were removed and weighed. A 2 x 2 inch 
skin section from the right dorsal area was excised and 
placed in 10% buffered formalin for 8 to 10 days. Four- to 
six-micron sagittal sections were taken, stained with 
hematoxylin and eosin, and the number of cells in 10 
random sebaceous glands was counted. 
The effect of flutamide on sebaceous gland sebum 
production was determined using ovariectomized rats, 
treated as described above . Sebum production was as-
sessed by measuring the increase in ether-extractable 
hair fat from days 16 to 24, according to the method of 
Ebling and Skinner [28], and was expressed as mg of hair 
fat/gm hair/24 hr. 
Studies in Hamsters 
Flutamide effects on androgen-stimulated hamster 
flank organ weight were measured following topical 
administration for 14 days. Groups of 6 mature , intact 
female or male golden Syrian hamsters (Lakeview Ham-
ster Colony, Newfield, New Jersey) weighing 100 to 130 
gm were housed singly and allowed access to food and 
water ad libitum. Females receiving exogenous androgen 
were treated with 125 ,.,.g of testosterone propionate (t .p. ) 
administered subcutaneously daily for 14 days (excluding 
weekends). Intact males did not receive additional andro-
gen. Various doses of topical flutamide in 10 ,.,.I of acetone 
were applied to the left flank organ only; right flank 
organs and flank organs of control animals received 
acetone alone. The hamsters were sacrificed following the 
treatment period and the flank organs were surgically 
excised and weighed . 
Tissues were fixed in neutral buffered formalin for 
histologic processing. Paraffin-embedded sections were 
stained with hematoxylin and eosin while formalin-fixed 
frozen sections were stained for lipid with 0.5% Oil Red 0 
in propylene glycol. 
Tissues were prepared for electron microscopy as 
previously described [22]. 
In order to evaluate the effect of topical flutamide 
treatment on the extent of in vitro 14C-incorporation into 
hamster flank organ lipids, female hamsters received t.p., 
or t.p. and topical flutamide, administered as described 
above. Following the treatment period animals were sac-
rificed, hair was removed by shaving and depilation, and 
both flank organs were surgically removed. The glands 
were minced, weighed, and incubated in the presence of 
14C-acetate for 3 hr at 37°C in 2 ml of Krebs- Ringer 
phosphate buffer (pH 7.4), as previously described [29]. 
Following incubation the tissues were digested in 15% 
ethanolic potassium hydroxide for 30 min at 70°C. The 
alkaline solution was acidified to pH 1 with 12 N HCl and 
the lipids were extracted with hexane. Aliquots of the 
extract were removed, transferred to scintillation vials, 
and the radioactivity determined by counting in an 
Intertechnique SL30 Liquid Scintillation-counter, using a 
toluene phosphor containing 4 gm 2,5-diphenyloxazole 
(PPO) and 50 mg 1,4-bis-(2- [5-diphenyloxazolyl]) ·bene-
zene (POPOP)/liter. The incorporation of 14C into the 
isolated lipid fraction was used as a proportional measure 
of lipogenic activity. 
Intact male hamsters were used to examine the effects 
of flutamide treatment on the pattern of in vitro incorpo-
ration of the label of sodium [1- 14C ]acetate into the lipids 
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of sebaceous glands and epidermis from flank organs. 
Flutamide, suspended in an aqueous carboxymethylcel-
lulose solution, was administered at 5 mg/day p.o. to 
groups of 12 male hamsters daily for 14 days (excluding 
weekends). At sacrifice both flank organs were removed, 
weighed, and the left flank organs incubated, as de-
scribed above . After incubation, sebaceous glands and 
epidermis were obtained following treatment of the gland 
specimens with 2 M calcium chloride solution, according 
to the method of Kellum [30]. Lipids were then extracted 
and subjected to thin-layer chromatographic analysis 
and autoradiography. Techniques for isolation of seba-
ceous glands and epidermis from hamster flank organs, 
lipid extraction and analysis by conventional TLC, and 
autoradiography have already been described [29]. 
RESULTS 
In none of the reported studies were significant 
differences observed in initial and final body 
weights between flutamide-treated animals and 
the appropriate controls. 
Studies in Castrate Rats 
Testosterone administration to ovariectomized 
rats caused significant (p < 0.01) hypertrophy and 
hyperplasia of the sebaceous glands, reflected in a 
2.2-fold increase in the average number of cells per 
skin sebaceous gland, and also in a 2.2-fold in-
crease in preputial gland weight (Fig. 1). Fluta-
mide completely inhibited these androgen-sensi-
tive parameters (Fig. 1), and they remained the 
same as the untreated control values. 
Testosterone caused significant (p < 0.01) 1.8-
fold stimulation of sebum production in ovariecto-
mized rats (Fig. 1). Simultaneous flutamide ad-
ministration effectively prevented these testoster-
one-induced increases, resulting in sebum levels 
actually lower than in untreated control animals. 
Studies in Hamsters 
The flank organ weights, following topical appli-
cation of flutamide to t.p.-treated female ham-
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FIG. 1. The effect of flutamide on Rebum production, 
and sebaceous cell count in skin sebaceous glands, and on 
preputial gland weights in ovariectomized rats receiving 
testosterone for 24 days. Each group contained 5 animals. 
The standard errors of the means are indicated by 
standard error bars. Stars represent significant differ-
ences (p <." 0.01) between androgen-treated rats, and rats 
receiving androgen and flutamide or untreated animals. 
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sters, are shown in Figure 2. T.p. increased the 
weight of both left and right flank organs 10.9- and 
13.2-fold over untreated flank organ weights, re-
spectively. Both left and right flank organs of 
hamsters given flutamide unilaterally at 0.5-3.0 
mg/day were significantly lighter than those in 
animals receiving t.p. alone (p < 0.01). At 0.1 
mg/day, only the right flank organ weight was 
statistically lower than the t.p. control. Left and 
right flank organ weights were not significantly 
different at any dose tested. Topical flutamide 
significantly (p < 0.01), and bilaterally, reduced 
flank organ weights in intact male hamsters at 
doses as low as 0.375 mg/day, the lowest dose 
tested (Fig. 3). 
Histologically, the sebaceous glands from fluta-
mide-treated male flank organs were markedly 
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FIG. 2. The effect of topically applied flutamide on the 
weight of flank organs from testosterone propionate 
(t.p.)-treated female hamsters. Groups of 6 animals 
received t.p. (125 J,tg/day s.c.) or t.p. and various doses of 
flutamide. The drug was applied topically in acetone to 
the left flank organ only, for 14 days (excluding week-
ends). The standard errors of the means are indicated by 
standard error bars. Stars represent significant differ-
ences (p < 0.01) between untreated or flutamide-treated 
animals, and hamsters receiving t.p . alone . 
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FIG. 3. The effects of topically applied flutamide on 
flank organ weights of intact male hamsters. Groups of 6 
animals received various topical doses of flutamide in 
acetone to the left flank organ only, for 14 days (excluding 
weekends). The standard errors of the means are indi-
cated by standard error bars. Stars represent significant 
differences (p < 0.01) between untreated and flutamide-
treated hamsters. 
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FIG. 4. Electron micrographs of sections from un-
treated (left) and flutamide-treated (right) intact male 
hamster flank organs. Note that flutamide induces reduc-
tion in lipid inclusions along with some cytoplasmic 
degeneration ( x 2900, left ; x 3700, right) . N = nucleus, L 
= lipid, W = whorls, V = vacuoles. 
reduced in size, when compared to normal, un-
treated flank organs. Furthermore, a quantitative 
reduction in Oil Red 0 positive lipid was also seen 
in sebaceous glands from treated flank organs . 
This reduction appeared to be related to a decrease 
in the number of mature sebaceous gland cells. 
The ultrastructure of the hamster flank organ 
was also altered following drug administration 
(Fig. 4). Mature sebaceous gland cells from un-
treated flank organs show a perinuclear distribu-
tion of large lipid bodies, extensive Golgi, cytoplas-
mic fibril inclusions, and numerous free ribosomes 
and polysomes. 
Topical administration of flutamide resulted in 
a reduction in lipid body size and in the formation 
of cytoplasmic vacuoles without osmophilic lipid 
inclusions. Membranous whorls , some with tubu-
lar profiles, were seen in association with remain-
ing lipid bodies and empty cytoplasmic vacuoles. 
There was a general reduction in cytoplasmic 
organelles, and focal cytoplasmic degeneration was 
evident in some cells. 
Systemic t.p. caused marked stimulation of 
lipogenesis in female flank organs, as measured by 
the in vitro incorporation of the label of 14C-acetate 
into lipids (Fig. 5). Topical application of fluta-
mide to one flank organ only elicited significant 
bilateral reductions of lipogenesis at dosages of 2.0 
and 3.0 mg/day (p < 0.05 and p < 0.01, respec-
tively). For all doses except 3.0 mg/day the degree 
of inhibition of lipogenesis was somewhat less than 
that observed for flank organ weight reductions 
(see Fig. 2). Thus, at doses of 0.1 , 0.5, 1.0, and 2.0 
mg/day, the inhibition of right flank weight was 4, 
16, 26, and 10% greater, respectively, than the 
corresponding reduction in lipogenesis. Similarly, 
at the same doses the contralateral (right) weight 
inhibition was 11, 16, 18, and 15% greater than the 
accompanying change in lipogenesis. 
Administration of flutamide to intact male ham-
sters at a daily dose of 5 mg/day p.o. for 14 days 
resulted in a 44% and 33% reduction in the weight 
of left and right flank organs, respectively. Thin-
layer chromatographic analysis of endogenous 
total lipids recovered from sebaceous glands of 
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untreated and flutamide-treated flank organs 
showed no gross differences (Fig. 6) between sam-
ples. Bands were observed corresponding in mobil-
ity to polar lipids (including phospholipids) , di-
glycerides and triglycerides, wax esters, steryl 
esters, and squalene. Because of differences in 
migration on different thin-layer plates, bands 
corresponding to the wax and steryl esters, and to 
squalene are shown at different positions, but the 
lipid class designations were assigned on the basis 
of co-chromatography with the authentic com-
pounds. 
The Table summarizes the patterns of in vitro 
incorporation of 14C from sodium acetate into the 
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FIG . 5. The effects of topical flutamide treatment on in 
vitro 14C-lipogenic activity of flank organs from testoster-
one propionate (t.p.)-treated female hamsters. Groups of 
6 animals received t.p. (125 J..Lg/day s.c.) or t.p. and 
various doses of flutamide applied topically in acetone to 
the left flank organ only, for 14 days (excluding week-
ends). The lipogenic activity was determined as de -
scribed in the text. The standard errors of the means are 
indicated by standard error bars. Double or single stars 
represent significant differences, at p < 0.01 and p < 
0.05, respectively, between untreated or flutamide-
treated animals, and hamsters receiving t.p. alone. 
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SEBACEOUS 
GLANDS 
-SQUALENE 
-STEROL ESTERS 
-WAX ESTERS ( MONOESTERS) 
-a- GLYCEROL ETHER 
DIESTERS 
- TRIGLYCERIDES 
- DIOL DIESTERS 
- FREE FATTY ACIDS 
- FREE STEROLS 
-DIGLYCERIDES 
-POLAR LIPIDS 
Sch 13521-TREATED 
SEBACEOUS 
GLANDS 
FIG. 6. Thin-layer chromatography of endogenous 
total lipids from sebaceous glands of untreated and 
flutamide (Sch 13521)-treated flank organs. Lipid (200 
J..Lg) from each tissue preparation was spotted on Silica 
Gel G; developed in hexane :benzene (1:1) to 18 em, 
hexane to 18 em, and hexane:diethyl ether:acetic acid 
(80:20:1) to 18 em; then sprayed with cupric acetate-
aqueous phosphoric acid and charred. Lipid class desig-
nations refer to position of authentic compounds, visual-
ized by charring. 
TABLE . The influence of flutamide treatment on patterns of incorporation of 14 C-acetate into the lipid fractions of 
isolated sebaceous !?lands and epidermis from male hamster flank orf.?ansa 
Isolated sebaceous Isolated flutamid
e- Appendage-freed 
treated sebaceous glands (12)" glands (12)" epidermis (12) h 
Polar lipids 
(including 27.9 ± 0.6 27.4 ± 1.3 38.9 ± 0.6 
phospholipids) 
Monoglycerides 1.0 ± 0.1 0.7 ± 0.1 2.5 ± 0.2 
Diglycerides 12.9 ± 0.3 11.9 ± 0.8 5.5 ± 0.3 
Free sterols 5.1 ± 0.2 4.0 ± 0.1 18.4 ± 0.1 
Free fatty acids 9. 3 ± 0.3 8.4 ± 0.5 11.1 ± 0.7 
(Diol diesters) 5.7 ± 0.3 5.9 ± 0.2 4.2 ± 0.3 
Triglycerides 24.5 ± 0.3 23.4 ± 0.2 1.0 ± 0.1 
(a-Glyceryl ether diesters) 0.5 ± 0.1 0.6 ± 0.1 -
Wax esters (monoesters) 2.5 ± 0.2 4.5 ± 0.3 5.8 ± 0.7 
Sterol esters 0.4±0.1 0.8 ± 0.1 1.4 ± 0.3 
Squalene 3.9 ± 0.2 3.6 ± 0.2 2.9 ± 0.2 
a Expressed as percent of total incorporation present in each lipid class ± standard error. 
b Number of samples. 
Flutamide-treated 
epidermis (12) h 
36.3 ± 1.4 
3.8 ± 0.4 
7.5 ± 0.2 
21.0 ± 0.5 
11.0 ± 0.7 
4.5 ± 0.4 
0.2 ± 0.1 
' 
-
4.5 ± 0.7 
1.0 ± 0.1 
2.8 ± 0.2 
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several lipid classes of flank organ sebaceous 
glands and epidermis from flutamide-treated and 
control animals. The percentages represent data 
pooled from analysis of 12 samples each of seba-
ceous gland and epidermal lipids. The patterns of 
incorporation for all preparations were remarkably 
consistent, with the greatest percentages of radio-
activity present in the polar lipids, and in seba-
ceous gland triglycerides. Significant sebaceous 
gland synthesis of diglycerides, free sterols and 
unesterified fatty acids, wax esters and squalene 
were also observed . Although sterol esters were not 
-..risualized by autoradiography within the exposure 
period, there was radioactivity present in this area 
in both epidermal and sebaceous gland prepara-
tions. The former showed significantly higher rela-
tive incorporation into both the sterol ester and the 
wax monoester fractions , when compared to seba-
ceous gland synthesis. As expected, the general 
pattern of epidermal lipids was significantly differ-
ent from that of sebaceous glands, the greatest 
differences being lower di- and tri-glycerides, and 
higher percentages of free sterols. Free fatty acids 
were evident in both the epidermal and sebaceous 
gland preparations . 
Only minor and inconsistent differences were 
noted between control and flutamide-treated ani-
mals (Tab. ). Flutamide-treated sebaceous glands 
showed slightly lowered levels of glycerides, free 
sterols, and fatty acids, and a slightly greater 
percentage of wax monoesters. Epidermal differ-
ences were also small, with slightly higher accumu-
lations of mono- and di-glycerides, and free sterols, 
and slightly lower synthesis of wax monoesters in 
the drug-treated epidermis. 
DISCUSSION 
Antiandrogens have intrigued dermatologists for 
a number of years because such agents may be 
able to control acne by reducing the activity of se-
baceous glands. The purpose of this study was to 
determine whether flutamide , a potent nonsteroi-
dal antiandrogen [22,23 ], suppressed sebaceous 
gland activity. Two test animals, the rat and the 
hamster, were employed to investigate these ef-
fects. 
As indicated by the studies reported here , in the 
rat flutamide prevented androgen-induced seba-
ceous gland hypertrophy and hyperplasia. These 
effects were monitored by examining changes in 
numbers of cells in cutaneous sebaceous glands, 
and in weight of the preputial gland, regarded as a 
sebaceous gland homologue. 
Flutamide 's inhibition of sebaceous gland func-
tion was reflected in decreased rat sebum produc-
tion. Inhibition of the latter is considered indica-
tive of high antisebum activity in man [24, 25] and 
is deemed more relevant to human sebaceous 
glands than is screening on the basis of secondary 
sex structure responses [25 ]. Although strict paral-
lelism to human sebum production has not yet 
been demonstrated, it is generally acknowledged 
that, as in humans, the primary constituent of hair 
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fat is sebum secreted by the sebaceous glands, 
with small but indeterminate amounts of lipid 
arising from the keratinizing epidermis and hair 
[31 ]. 
The second test animal, the golden Syrian ham-
ster, possesses flank organs, also termed cos-
tovertebral organs or flank glands, which are 
paired androgen-responsive areas on either flank 
(4]. Thus, if male hamsters are castrated, the flank 
organs diminish in size and approach that of the 
female flank organs. Alternatively, administration 
of androgens to castrated males or intact females 
markedly increases the size of the flank organs. 
Microscopically, androgen-stimulated flank organs 
are characterized by large sebaceous glands with 
patulous openings to the surface. Nonstimulated 
flank organs contain much smaller glands [4]. The 
hamster, therefore, appears to be an acceptable 
animal to determine topical efficacy of agents 
which affect sebaceous gland function, inasmuch 
as the contralateral organ of the same animal may 
be utilized as a control indicator of systemic 
activity. 
Using this test animal we have demonstrated 
that flutamide inhibits androgen-induced flank 
organ growth in female and male hamsters in a 
dose-responsive manner, and we have shown an 
effect on in vitro lipogenesis, though the effects on 
the two parameters were only equivalent at doses 
of 2 and 3 mg/day. Although the flutamide was 
applied topically, a purely local effect of this drug 
could not be demonstrated; responses were similar 
on the treated and untreated flanks. Although it 
seems likely that the contralateral effect occurred 
via systemic absorption, the possibility of a direct 
effect on sebaceous glands within the treated area 
cannot be excluded on the basis of the described 
studies. Despite the topical application , the possi-
bility of systemic effects through oral ingestion (by 
licking the area of application) remained. Through 
daily observation this was found not to occur, al-
though the nocturnal activities of these animals 
could have led to systemic effects. 
Sebaceous glands from flutamide-treated flank 
organs were histologically characterized by marked 
atrophy and a reduction in Oil Red 0 positive lipid. 
Evaluation of the ultrastructure of sebaceous gland 
cells from treated hamsters showed a loss of 
cytoplasmic lipid bodies, whorled membrane for-
mation around cytoplasmic vacuoles, and reduc-
tions in cytoplasmic fibrillar inclusions and organ-
elles. Similar histologic and ultrastructural 
changes have been reported to occur after castra-
tion of male hamsters [32]. 
The profound effects of flutamide on hamster 
flank organ tissue prompted us to examine the 
effects of the drug on the pattern of in vitro lipid 
synthesis following treatment. The methodology 
reported by Kellum was used to obtain relatively 
pure preparations of sebaceous glands and epider-
mis; we have previously shown such preparations 
to be histologically intact and free of other epider-
mal or dermal contamination [29]. The extremely 
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small amounts of lipid extracted from isolated 
sebaceous glands and epidermis precluded deter-
mination of the actual weights of lipid obtained. 
We have found, however, that extractable lipid 
represents 25% of the wet weight of whole male 
flank organs, a proportion unchanged by flutamide 
treatment (Lutsky, unpublished observations). 
Since these organs are composed largely of seba-
ceous glands [33] it would not be invalid to assume 
that flutamide decreases total sebaceous gland 
lipid in the same manner. 
The failure of flutamide to significantly alter the 
pattern of endogenous flank organ sebaceous gland 
lipids (Fig. 6), or of in vitro 14C-lipid synthesis 
(Tab.) within the 14-day treatment period, while 
affecting other parameters of sebaceous gland 
activity (e.g., flank organ growth and sebum pro-
duction), may be a manifestation of this com-
pound's inability to completely inhibit androgen-
stimulated sebaceous gland lipogenesis while it is 
able to inhibit sebaceous cell maturation (resulting 
in decreased flank organ weight and sebum pro-
duction). Alternatively, it is entirely possible that 
the various pathways of sebaceous lipid synthesis 
could be affected similarly by androgen depriva-
tion, no matter how long the treatment period. 
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